Sharescart Research Club logo
Apollo Green 56 (-6.7%)ASK Investment 925 (-2.1%)Axles India 505 (-3.8%)CIAL 438 (0%)CSK 264 (0.8%)ESDS Software 458 (2.2%)Garuda Aerospace 478 (-1.4%)Incred Holdings 150 (-1.3%)India Carbon 895 (0%)Indian Potash 2850 (0%)Inox Clean 725 (-3.3%)Insolare Energy 185 (0%)Lava 52 (8.3%)Motilal Oswal 12.5 (-3.5%)MSEI 6.25 (-2.3%)NCDEX 384 (-5.2%)NeRL 56 (-3.4%)NSE 2050 (6.5%)OYO 24 (0%)OYO Assets 9.95 (-17.1%)Pharmeasy 6.25 (0%)Polymatech Electronics 60 (-3.2%)RRP S4E 168 (0%)SBI Mutual 775 (0%)Taparia Tools 6050 (0%)Ticker Ltd 32 (0%)Zepto 48 (-4%)

15 Days Price Change

Modern Diagnostic IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 26.44 Cr
Profile
Price Range 85  to  90 per share
Profile
Min Investment ₹90
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are a services provider in diagnostic and related healthcare tests services in India. We offer a one-stop solution for pathologyand radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through our integrated,nationwide network, we offer a complete range of diagnostic facilities in radiology and pathology. We provide healthcare testsand services for use in core testing, patients’ diagnosis and prevention, monitoring of disease and other health conditions. Ourcustomers include individual patients, hospitals and other healthcare providers and corporate customers. Read More

Basic Info

Face Value 10 per share

Price 85  to  90 per share

P/E (x) 11

Sales( Cr.) 78

PAT( Cr.) 9

EPS 8.2

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Devendra Singh Yadav Deepali Yadav Asha Yadav Jitendra Singh

Pre Issue Share Holding 100%

Post Issue Share Holding 72.85%

Listing Details:

Listing Price: 99.5

Listing Gain: 9.55%

Current Price: 80.3

Gain On Issue: 80.3 | 0%

GMP: 14

GMP %: 15.6 %

IPO Tentative Timetable

Opening Date Dec 31, 2025
Closing Date Jan 02, 2026
Allotment Jan 05, 2026
Refund Jan 06, 2026
Delivery of Shares Jan 06, 2026
Listing Date Jan 07, 2026

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 3200 288,000
Retail (Max) -- -- --
S-HNI (Min) 1 3200 288,000
S-HNI (Max) 3 9600 864,000
B-HNI (Min) 4 12800 1,152,000

Objective of the Issue

We intend to utilize the net proceeds of the Issue to meet the following objects: -1. Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories 2. Funding Working Capital Requirement 3. Repayment of certain outstanding borrowings availed by our Company 4. General Corporate Purpose

Issue

Category Nos Bid Bid (x)
QIB 782400 151400000 193.5x
NII 792000 411345600 519.4x
Retail 1363200 466844800 342.5x
EMP 0 0 0x
Total 2937600 1029590400 350.5x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Modern Diagnostic Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 60 56 67 78
Other Income 0 0 2 1
Total Income 61 57 69 79
Total Expenditure 54 57 56 60
Operating Profit 6 -1 13 19
Interest 2 1 2 2
Depreciation 4 4 4 4
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 1 -6 7 13
Provision for Tax 3 -0 1 4
Profit After Tax -1 -6 6 9
Adjustments 0 0 0 0
Profit After Adjustments -1 -6 6 9
Adjusted Earnings Per Share -1.3 -5.2 5.3 8.2

Modern Diagnostic Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 12 6 12 21
Minority's Interest 0 0 0 0
Borrowings 13 6 10 8
Other Non-Current Liabilities 3 4 4 4
Total Current Liabilities 20 21 24 32
Total Liabilities 49 37 49 65
Fixed Assets 24 24 27 31
Other Non-Current Assets 6 1 4 10
Total Current Assets 18 12 18 24
Total Assets 49 37 49 65

Modern Diagnostic Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 5 0 0
Cash Flow from Operating Activities 4 -0 8 14
Cash Flow from Investing Activities -5 2 -11 -13
Cash Flow from Financing Activities 5 -6 3 -0
Net Cash Inflow / Outflow 3 -4 0 0
Closing Cash & Cash Equivalent 5 0 0 1

Modern Diagnostic Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1.32 -5.21 5.27 8.15
CEPS(Rs) 2.01 -1.69 8.83 11.96
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 10.63 5.42 10.69 18.84
Core EBITDA Margin(%) 9.95 -1.75 16.46 23.05
EBIT Margin(%) 4.49 -8.05 12.92 18.77
Pre Tax Margin(%) 1.89 -10.56 10.23 16.32
PAT Margin (%) -2.41 -10.18 8.63 11.51
Cash Profit Margin (%) 3.67 -3.31 14.48 16.88
ROA(%) -2.98 -13.45 13.47 15.73
ROE(%) -12.41 -64.92 65.4 55.21
ROCE(%) 8.43 -16.98 32.42 39
Receivable days 54.57 55.32 50.06 54.11
Inventory Days 9.16 11.22 13.37 18.47
Payable days 172.39 190.05 173.44 163.15
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.28 0.29 0.31 0.41
EV/Core EBITDA(x) 2.63 -24.34 1.67 1.72
Net Sales Growth(%) 0 -6.52 19.28 16.11
EBIT Growth(%) 0 -267.57 291.34 68.76
PAT Growth(%) 0 -294.93 201.1 54.76
EPS Growth(%) 0 -294.93 201.1 54.76
Debt/Equity(x) 1.74 2.57 1.74 1.07
Current Ratio(x) 0.87 0.58 0.75 0.75
Quick Ratio(x) 0.8 0.49 0.63 0.59
Interest Cover(x) 1.73 -3.21 4.8 7.67
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 16% 9% 0% 0%
Operating Profit CAGR 46% 47% 0% 0%
PAT CAGR 50% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 55% 19% 11% 11%
ROCE Average 39% 18% 16% 16%

Company Contact Information

Modern Diagnostic & Research Centre Ltd.

Priyanshu Yadav

91 9999474297

compliance@mdrcindia.com

Plot No H-64,1st Floor Blk- H, Bali Nagar City Landmark Near Khetar Pal Hospital Ramesh Nagar, West Delhi

IPO Lead Manager(s)

Modern Diagnostic & Research Centre Ltd.

Beeline Capital Advisors Pvt Ltd.

Registrar Info

Modern Diagnostic & Research Centre Ltd.

MUFG Intime India Pvt Ltd.

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai (Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra

+91 810 811 8484

91-022-49186060

rnt.helpdesk@in.mpms.mufg.com

https://in.mpms.mufg.com/

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp